CSIMarket
 
Novan Inc   (NOVN)
Other Ticker:  
 
 

Novan Inc Growth Comparisons

Select each growth Category to receive further Information



NOVN Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) 64.21 % -8.33 % -4.67 % 3.04 %
Q / Q Revenue Growth (Q1 MRQ) -69.79 % -7.11 % -4.46 % -3.86 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 512.74 % -0.3 % 1.07 % %
Seq. Revenue Growth (for 12 months ending Q1 TTM) 5.23 % -2.26 % -1.3 % 0.64 %
Revenue 5 Year Average Growth 61.73 % 14.14 % 10.74 % 11.12 %


NOVN's Growth Comparisons in I. Quarter 2023




Novan Inc showed impressive 64.21% year on year rise in the first quarter 2023 to 3 millions, despite the -8.33% in the Major Pharmaceutical Preparations industry, Healthcare sector decreased -4.67%. Despite modest Sales in the Healthcare sector and the Major Pharmaceutical Preparations industry, Novan Inc reported above average market Sales growth.

Top-line fell by -69.79% from the forth quarter results. Comparing the annual growth, sales of 61.73% on average in last five years, to the S & P 500's, including only Businesses with the first quarter 2023 financial results, average yearly sales growth is 11.12%. Novan Inc grew faster than the market.


Growth Rates of NOVN's Income in the first quarter 2023


NOVN Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) - -28.95 % -16.01 % -0.08 %
Seq. Operating Income Change (Q1 MRQ) - -23.35 % -19.41 % 1.83 %
Y / Y Operating Income Growth (Q1 TTM) - 2.87 % -12.55 % 0.48 %
Seq. Operating Income Growth (Q1 TTM) - -7.82 % -4.05 % -0.08 %
Operating Income 5 Year Avg. Change - 33.52 % 10.15 % 10.87 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) - -64.72 % -29 % -0.44 %
Seq. Income from Cont. Ops. Change (Q1 MRQ) - -44.86 % -31.32 % 14.75 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) - -24.75 % -37.25 % -3.84 %
Seq. Income from Cont. Ops. Change (Q1 TTM) - -17.83 % -5.91 % -0.18 %
Income from Cont. Ops. 5 Year Avg. Change - 57.24 % 23.15 % 2.84 %

NOVN Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) - -64.25 % -28.67 % -0.81 %
Q / Q Net Income Growth (Q1 MRQ) - -44.61 % -31.51 % 12.92 %
Y / Y Net Income Change (Q1 TTM) - -22.96 % -35.24 % -4.52 %
Seq. Net Income Change (Q1 TTM) - -17.35 % -5.15 % -0.25 %
Net Income 5 Year Avg. Growth - 57.4 % 23.18 % 3.12 %

NOVN's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) - -65.22 % -29 % -0.44 %
Seq. EPS from Cont. Ops. Change (Q1 MRQ) - -35.81 % -31.32 % 14.75 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q1 TTM) - - - 0.21 %
EPS from Cont. Ops. 5 Year Avg. Growth - 32.23 % 23.15 % 2.84 %



NOVN EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) - -64.75 % -28.67 % -0.81 %
Q / Q EPS Net Growth (Q1 MRQ) - -35.52 % -31.51 % 12.92 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - -9.85 %
Seq. EPS Net Change (for 12 months ending Q1 TTM) - - - -0.65 %
EPS Net 5 Year Avg. Change - 57.4 % 23.18 % 3.12 %



Novan Inc reported bottom-line of $ -0.54 in the first quarter, compare to $ -0.71 in the same quarter a year ago. Major Pharmaceutical Preparations industry fell by -64.75%, while Healthcare sector decreased by -28.67%, and overall market declined by -0.81%.

Bottom-line fell by -69.79% from the forth quarter results. Comparing the annual growth, income per share of 61.73% on average in last five years, to the S & P 500's, including only Businesses with the first quarter 2023 earnings, average yearly income per share growth is 3.12%. Novan Inc grew faster than the market.

NOVN Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) - -49.91 % -41.36 % 4.16 %
Seq. Free Cash Flow Change (Q1 MRQ) - -57.18 % -54.44 % -61.5 %
Y / Y Free Cash Flow Change (Q1 TTM) - -15.72 % -16.85 % 4.91 %
Seq. Free Cash Flow Change (Q1 TTM) - -8.93 % -6.3 % -0.04 %
Free Cash Flow 5 Year Avg. Change - 27.42 % 18.45 % 23.3 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - - - -
Seq. Net Cash Flow Change (Q1 MRQ) - 26.53 % - -
Y / Y Net Cash Flow Change (Q1 TTM) - 568.74 % - -
Seq. Net Cash Flow Change (Q1 TTM) - - - -
Net Cash Flow 5 Year Avg. Change - - 0.72 % 48.8 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) -97.52 % 17.61 % 14.48 % 12.87 %
Seq. Capital Expenditures Change (Q1 MRQ) -97.84 % -15.72 % -14.02 % -29.2 %
Y / Y Capital Expenditures Change (Q1 TTM) -62.75 % 13.9 % 10.76 % -4.62 %
Seq. Capital Expenditures Change (Q1 TTM) -21.17 % 4.25 % 3.39 % 0.85 %
Capital Expenditures 5 Year Avg. Change 14.54 % 13.29 % 9.25 % 8.65 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com